Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors

NCT02921984 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Salivary Gland Tumors
Head and Neck Cancer

Interventions

DRUG: Docetaxel
RADIATION: Intensity-modulated radiotherapy
DRUG: Pemetrexed
DRUG: Cisplatin

Sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University